Results 161 to 170 of about 5,054 (206)

Comparative Effectiveness of Four Biologics for Moderate-to-Severe Plaque Psoriasis: A Network Meta-Analysis. [PDF]

Cureus
Abdullah A, Polus L.
europepmc   +1 more source

Potential Blood Biomarkers Predicting Treatment Response in Psoriasis: A Systematic Review and Meta-Analysis. [PDF]

J Clin Med
Villa-Gonzalez JM, Arevalo-Ortega I, Gonzalez-Hermosa MR, Gonzalez S, Rashid S, Tsao H, Izu-Belloso R.   +6 more
europepmc   +1 more source

Post-Marketing Safety Profile of Mirikizumab: A Multi-Database Pharmacovigilance Study Using FAERS and JADER with IL-23 Inhibitor Class Comparison. [PDF]

Bioengineering (Basel)
Choi JG, Gong EJ, Bang CS, Lee JJ.
europepmc   +1 more source

Efficacy and safety of interleukin inhibitors in the treatment of moderate-to-severe plaque psoriasis: a systematic review and network meta-analysis. [PDF]

Front Med (Lausanne)
Ming J, Jiang Y, Wu Q, Xiao X, Chen M.
europepmc   +1 more source

Guselkumab for plaque psoriasis

, 2019
openaire   +1 more source

Guselkumab for the treatment of psoriasis

Expert Opinion on Biological Therapy, 2018
Psoriasis is a chronic immune mediated disease in which the interplay of T cells and keratinocytes seems to play a key role. In this context, the interleukin (IL)-23/IL-17 axis is currently considered to be crucial in the pathogenesis of psoriasis and the selective inhibition of IL-23 may be viewed as an improvement of treatments blocking both IL-23 ...
Anna Balato, Annunziata Raimondo, Matteo Megna   +2 more
exaly   +10 more sources

Some of the next articles are maybe not open access.

Related searches:

Guselkumab for the treatment of palmoplantar pustulosis

Expert Opinion on Biological Therapy, 2020
Palmoplantar pustulosis, or pustulosis palmaris et plantaris (PPP), is a chronic, recurrent inflammatory skin disease that is sometimes unresponsive to conventional therapy. The anti-interleukin 23 antibody guselkumab is effective for treating PPP.This review details the current understanding of PPP and discusses why guselkumab may be effective ...
Masamoto Murakami
exaly   +3 more sources

Development and validation of immunoassays for monitoring of guselkumab and anti-guselkumab antibodies in patients with moderate-to-severe psoriasis [PDF]

Journal of Pharmaceutical and Biomedical Analysis, 2020
Therapeutic drug monitoring, which is the measurement of drug concentrations in the blood, is a useful tool to guide clinical decision-making and treatment adjustments, on the condition that drug concentrations are correlated with treatment response. For
Ann Gils, Els Brouwers, Lynda Grine
exaly   +2 more sources